1. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets
   Cecilia Pop-Bica et al, 2017, IJMS CrossRef
2. MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C
   GUANGYAN LI et al, 2016 CrossRef
3. MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS
   Yongqi Long et al, 2016 CrossRef
4. Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy
   DAVID SMID et al, 2016 CrossRef
5. Redox Regulation and Noncoding RNAs
   Matthias S. Leisegang et al, 2017, Antioxidants & Redox Signaling CrossRef
6. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
   Bernhard Biersack, 2017, Non-coding RNA Research CrossRef
7. RLIP76-dependent suppression of PI3K/AKT/Bcl-2 pathway by miR-101 induces apoptosis in prostate cancer
   Jing Yang et al, 2015, Biochemical and Biophysical Research Communications CrossRef
8. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1
   Lin Zhu et al, 2018, CBM CrossRef
9. The role of microRNAs in bladder cancer.
   Hideki Enokida et al, 2016, Investig Clin Urol CrossRef
10. Development of a novel drug targeting delivery system for cervical cancer therapy
    Li Xiao et al, 2019, Nanotechnology CrossRef
11. A miRNA-101-3p/Bim axis as a determinant of serum deprivation-induced endothelial cell apoptosis
    Ji-Hee Kim et al, 2017, Cell Death Dis CrossRef
12. MicroRNAs: Key Players in Bladder Cancer.
    Qi Li et al, 2019, Mol Diagn Ther CrossRef
13. Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs
    Ruixia Ma et al, 2015, Curr Pharmacol Rep CrossRef
14. rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression
    Ying Deng et al, 2015, Biochemical and Biophysical Research Communications CrossRef
15. MicroRNA-101 protects cardiac fibroblasts from hypoxia-induced apoptosis via inhibition of the TGF-β signaling pathway
    Xin Zhao et al, 2015, The International Journal of Biochemistry & Cell Biology CrossRef
16. Garcinol downregulates Notch1 signaling via modulating miR-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells
    Chi-Cheng Huang et al, 2017, Biotechnology and Applied Biochemistry CrossRef
17. A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma
    Deborah W. Knapp et al, 2016, BLC CrossRef
18. 1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p
    Yingyu Ma et al, 2017, Oncotarget CrossRef
19. MicroRNA‑101 inhibits cell migration and invasion in bladder cancer via targeting FZD4
    Lei Chen et al, 2018, Exp Ther Med CrossRef
20. MicroRNA-101 inhibits cadmium-induced angiogenesis by targeting cyclooxygenase-2 in primary human umbilical vein endothelial cells
    Lin Che et al, 2020, Biochemical Pharmacology CrossRef
21. Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells
    Amir Sadra Zangouei et al, 2020, Diagn Pathol CrossRef
22. MicroRNAs and target molecules in bladder cancer
    Payam Kheirmand Parizi et al, 2020, Med Oncol CrossRef
23. Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
    Chunyu Zhang et al, 2021, Front. Oncol. CrossRef
24. Molecular markers of systemic therapy response in urothelial carcinoma
    Francesco Claps et al, 2021, Asian Journal of Urology CrossRef
25. Emerging Strategies for Sensitization of Therapy Resistant Tumors Toward Cancer Therapeutics by Targeting the Bcl-2 Family, TGF-β, Wnt/β-Catenin, RASSF and miRNA Regulated Signaling Pathways
    Veerasamy Tarmarajen et al, 2021, The International Journal of Biochemistry & Cell Biology CrossRef
26. Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
    Alba Loras et al, 2021, Cancers CrossRef
27. The Role of MicroRNA in the Metastatic Phenotype of Bladder Cancer
    Aaron Perecman et al, 2022 CrossRef
28. NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101/VEGF-C pathway in vitro and in vivo
    Huihui Zhang et al, 2022, BMC Urol CrossRef
29. The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment
    Sanjna Das et al, 2023, IJMS CrossRef
30. miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay – A review
    Hesham A. El-Mahdy et al, 2023, Pathology - Research and Practice CrossRef
31. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms.
    Fei Li et al, 2023, Drug Resist Updat CrossRef
32. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism
    Mehrdad Hashem et al, 2024, Non-coding RNA Research CrossRef
33. The Role of Tumor‐Derived Extracellular Vesicles in Drug Resistance in Urologic Cancers
    Zhuang Xiong et al, 2024, Advanced Therapeutics CrossRef
34. Bladder cancer: non-coding RNAs and exosomal non-coding RNAs
    Jingang Zhao et al, 2024, Funct Integr Genomics CrossRef
35. Contemporary Molecular Markers for Predicting Systemic Treatment Response in Urothelial Bladder Cancer: A Narrative Review
    George Dimitrov et al, 2024, Cancers CrossRef